- Home
- GLPG vs AMPL Comparison
GLPG vs AMPL Comparison
Compare GLPG & AMPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- AMPL
- Stock Information
- Founded
- GLPG 1999
- AMPL 2012
- Country
- GLPG Belgium
- AMPL United States
- Employees
- GLPG N/A
- AMPL N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- AMPL EDP Services
- Sector
- GLPG Health Care
- AMPL Technology
- Exchange
- GLPG Nasdaq
- AMPL Nasdaq
- Market Cap
- GLPG 1.8B
- AMPL 1.5B
- IPO Year
- GLPG 2005
- AMPL 2021
- Fundamental
- Price
- GLPG $28.83
- AMPL $12.72
- Analyst Decision
- GLPG Sell
- AMPL Buy
- Analyst Count
- GLPG 4
- AMPL 10
- Target Price
- GLPG $25.33
- AMPL $13.40
- AVG Volume (30 Days)
- GLPG 238.0K
- AMPL 1.2M
- Earning Date
- GLPG 07-23-2025
- AMPL 08-07-2025
- Dividend Yield
- GLPG N/A
- AMPL N/A
- EPS Growth
- GLPG N/A
- AMPL N/A
- EPS
- GLPG N/A
- AMPL N/A
- Revenue
- GLPG $311,493,731.00
- AMPL $306,601,000.00
- Revenue This Year
- GLPG $0.78
- AMPL $12.82
- Revenue Next Year
- GLPG N/A
- AMPL $10.82
- P/E Ratio
- GLPG N/A
- AMPL N/A
- Revenue Growth
- GLPG 18.32
- AMPL 8.56
- 52 Week Low
- GLPG $22.36
- AMPL $7.37
- 52 Week High
- GLPG $31.23
- AMPL $14.88
- Technical
- Relative Strength Index (RSI)
- GLPG 61.65
- AMPL 56.60
- Support Level
- GLPG $26.62
- AMPL $11.87
- Resistance Level
- GLPG $28.28
- AMPL $12.71
- Average True Range (ATR)
- GLPG 0.55
- AMPL 0.47
- MACD
- GLPG 0.03
- AMPL -0.02
- Stochastic Oscillator
- GLPG 92.86
- AMPL 81.60
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
About AMPL Amplitude Inc.
Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue primarily through selling subscriptions to the platform. The company derives a majority of its revenue from the United States.